FDA Adverse Event Malfunction Summary report: N

CAPSTONE SPINAL SYSTEM

MDR report key: 6753244 · Received July 31, 2017

Report

Report Number
1030489-2017-01829
Event Type
Malfunction
Date Received
July 31, 2017
Date of Event
July 3, 2017
Report Date
September 28, 2017
Manufacturer
MDT SOFAMOR DANEK PUERTO RICO MFG
Product Code
MAX
PMA / PMN Number
SEE H10
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PO
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS PART IS NOT APPROVED FOR USE IN THE US, HOWEVER A LIKE DEVICE WITH PART# 2990826, 510K# K073291 AND (B)(4) IS APPROVED FOR THE US MARKET. NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT.

Additional Manufacturer Narrative · 1

PRODUCT ANALYSIS: VISUAL AND MICROSCOPIC EXAMINATION IDENTIFIED A ~3MM PORTION OF THE TOP FACE OF THE IMPLANT, WHICH INTERFACES DIRECTLY WITH THE INSERTER. OPTICAL AND MICROSCOPIC EXAMINATION OF THE RETURNED PORTION OF THE IMPLANT IDENTIFIED A BRITTLE FRACTURE WITH RAYS EMANATING FROM THE ROOT OF THE THREAD TOOTH. ADDITIONALLY, THE CORNER OF THE INSERTER INTERFACE IS FRACTURED WITH AN ANGULATED CRACK, CONSISTENT WITH A TORSIONAL COMPONENT. THE ABOVE OBSERVATIONS ARE CONSISTENT WITH SIGNIFICANT FORCE DURING ATTEMPTED IMPLANTATION. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

PRE-OP DIAGNOSIS: SPONDYLOLISTHESIS L5-S1 PROCEDURE USED: TRANSFORAMINAL LUMBAR INTERBODY FUSION- MAST IT WAS REPORTED THAT DURING SURGERY THE DEVICE BROKE WHILE POSITIONING. MOST OF THE IMPLANT COULD NOT BE EXPLANTED. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
533749 CAPSTONE SPINAL SYSTEM INTERVERTEBRAL FUSION DEVICE WITH BONE GRAFT, LUMBAR MAX MDT SOFAMOR DANEK PUERTO RICO MFG NA H5182702

Patients

Seq Age Sex Outcome Treatment
1 53 YR